These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30677622)

  • 1. Alteration in endothelial permeability occurs in response to the activation of PAR2 by factor Xa but not directly by the TF-factor VIIa complex.
    Benelhaj NE; Maraveyas A; Featherby S; Collier MEW; Johnson MJ; Ettelaie C
    Thromb Res; 2019 Mar; 175():13-20. PubMed ID: 30677622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa.
    Camerer E; Huang W; Coughlin SR
    Proc Natl Acad Sci U S A; 2000 May; 97(10):5255-60. PubMed ID: 10805786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apixaban Suppresses the Release of TF-Positive Microvesicles and Restrains Cancer Cell Proliferation through Directly Inhibiting TF-fVIIa Activity.
    Featherby S; Madkhali Y; Maraveyas A; Ettelaie C
    Thromb Haemost; 2019 Sep; 119(9):1419-1432. PubMed ID: 31266079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells.
    Morris DR; Ding Y; Ricks TK; Gullapalli A; Wolfe BL; Trejo J
    Cancer Res; 2006 Jan; 66(1):307-14. PubMed ID: 16397244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protease-activated receptors-1 and -2 can mediate endothelial barrier protection: role in factor Xa signaling.
    Feistritzer C; Lenta R; Riewald M
    J Thromb Haemost; 2005 Dec; 3(12):2798-805. PubMed ID: 16359518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering of substrate selectivity for tissue factor.factor VIIa complex signaling through protease-activated receptor 2.
    Larsen KS; Ostergaard H; Olsen OH; Bjelke JR; Ruf W; Petersen LC
    J Biol Chem; 2010 Jun; 285(26):19959-66. PubMed ID: 20388709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation of tissue factor-factor VIIa-factor Xa complex induces activation of the mTOR pathway which regulates migration of human breast cancer cells.
    Jiang X; Zhu S; Panetti TS; Bromberg ME
    Thromb Haemost; 2008 Jul; 100(1):127-33. PubMed ID: 18612547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor production by fibroblasts in response to factor VIIa binding to tissue factor involves thrombin and factor Xa.
    Ollivier V; Chabbat J; Herbert JM; Hakim J; de Prost D
    Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1374-81. PubMed ID: 10807756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of tissue factor-factor VIIa-factor Xa complex promotes cellular signaling and migration of human breast cancer cells.
    Jiang X; Bailly MA; Panetti TS; Cappello M; Konigsberg WH; Bromberg ME
    J Thromb Haemost; 2004 Jan; 2(1):93-101. PubMed ID: 14717972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional program induced by factor VIIa-tissue factor, PAR1 and PAR2 in MDA-MB-231 cells.
    Albrektsen T; Sørensen BB; Hjortø GM; Fleckner J; Rao LV; Petersen LC
    J Thromb Haemost; 2007 Aug; 5(8):1588-97. PubMed ID: 17470200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protease-activated receptor 2 (PAR2) mediates vascular smooth muscle cell migration induced by tissue factor/factor VIIa complex.
    Marutsuka K; Hatakeyama K; Sato Y; Yamashita A; Sumiyoshi A; Asada Y
    Thromb Res; 2002 Sep; 107(5):271-6. PubMed ID: 12479889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor VIIa-induced interaction with integrin controls the release of tissue factor on extracellular vesicles from endothelial cells.
    Rothmeier AS; Versteeg HH; Ruf W
    J Thromb Haemost; 2019 Apr; 17(4):627-634. PubMed ID: 30740873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of the specificity of protease-activated receptors 1 and 2 signaling by factor Xa and thrombin.
    Rana S; Yang L; Hassanian SM; Rezaie AR
    J Cell Biochem; 2012 Mar; 113(3):977-84. PubMed ID: 22034092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential role of activated factor VIII (FVIIIa) in FVIIa/tissue factor-dependent FXa generation in initiation phase of blood coagulation.
    Furukawa S; Nogami K; Ogiwara K; Shima M
    Int J Hematol; 2019 Apr; 109(4):390-401. PubMed ID: 30756344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TF:FVIIa-specific activation of CREB upregulates proapoptotic proteins via protease-activated receptor-2.
    Versteeg HH; Borensztajn KS; Kerver ME; Ruf W; Reitsma PH; Spek CA; Peppelenbosch MP
    J Thromb Haemost; 2008 Sep; 6(9):1550-7. PubMed ID: 18647225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The endothelial protein C receptor supports tissue factor ternary coagulation initiation complex signaling through protease-activated receptors.
    Disse J; Petersen HH; Larsen KS; Persson E; Esmon N; Esmon CT; Teyton L; Petersen LC; Ruf W
    J Biol Chem; 2011 Feb; 286(7):5756-67. PubMed ID: 21149441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matriptase activation connects tissue factor-dependent coagulation initiation to epithelial proteolysis and signaling.
    Le Gall SM; Szabo R; Lee M; Kirchhofer D; Craik CS; Bugge TH; Camerer E
    Blood; 2016 Jun; 127(25):3260-9. PubMed ID: 27114461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rivaroxaban, a specific FXa inhibitor, improved endothelium-dependent relaxation of aortic segments in diabetic mice.
    Pham PT; Fukuda D; Yagi S; Kusunose K; Yamada H; Soeki T; Shimabukuro M; Sata M
    Sci Rep; 2019 Aug; 9(1):11206. PubMed ID: 31371788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesis.
    Norledge BV; Petrovan RJ; Ruf W; Olson AJ
    Proteins; 2003 Nov; 53(3):640-8. PubMed ID: 14579355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue Factor/ FVIIa prevents the extrinsic pathway of apoptosis by regulation of the tumor suppressor Death-Associated Protein Kinase 1 (DAPK1).
    Aberg M; Johnell M; Wickström M; Siegbahn A
    Thromb Res; 2011 Feb; 127(2):141-8. PubMed ID: 21168190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.